The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AFFYMETRIX INC | COM | 00826T108 | 713 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 13,460 | 1,670,000 | SH | SOLE | 1,670,000 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 1,434 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | ||
BIND THERAPEUTICS INC | COM | 05548N107 | 5,107 | 427,000 | SH | SOLE | 427,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADR | 09071M106 | 3,236 | 1,451,000 | SH | SOLE | 1,451,000 | 0 | 0 | ||
CATALYST PHARM PARTNERS INC | COM | 14888U101 | 3,116 | 1,378,584 | SH | SOLE | 1,378,584 | 0 | 0 | ||
CELATOR PHARMACEUTICALS INC | COM | 15089R102 | 1,031 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
CELGENE CORP | RIGHTS 12/31/2030 | 151020112 | 1,881 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
CEMPRA INC | COM | 15130J109 | 5,544 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 12,242 | 536,000 | SH | SOLE | 536,000 | 0 | 0 | ||
CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 4,292 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 1,425 | 698,300 | SH | SOLE | 698,300 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 2,630 | 115,500 | SH | SOLE | 115,500 | 0 | 0 | ||
EVOKE PHARMA INC | COM | 30049G104 | 1,956 | 233,400 | SH | SOLE | 233,400 | 0 | 0 | ||
FLEXION THERAPEUTICS INC | COM | 33938J106 | 2,229 | 135,500 | SH | SOLE | 135,500 | 0 | 0 | ||
FLUIDIGM CORP DEL | COM | 34385P108 | 3,966 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
GENMARK DIAGNOSTICS INC | COM | 372309104 | 4,324 | 435,000 | SH | SOLE | 435,000 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 2,299 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
INSPIREMD INC | COM NEW | 45779A309 | 6,560 | 2,150,000 | SH | SOLE | 2,150,000 | 0 | 0 | ||
KALOBIOS PHARMACEUTICALS INC | COM | 48344T100 | 1,474 | 545,000 | SH | SOLE | 545,000 | 0 | 0 | ||
KIPS BAY MED INC | COM | 49726K105 | 540 | 777,531 | SH | SOLE | 777,531 | 0 | 0 | ||
LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 2,354 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 838 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 4,116 | 167,600 | SH | SOLE | 167,600 | 0 | 0 | ||
NPS PHARMACEUTICALS INC | COM | 62936P103 | 4,490 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
OMEROS CORP | COM | 682143102 | 6,036 | 500,100 | SH | SOLE | 500,100 | 0 | 0 | ||
PHARMACYCLICS INC | COM | 716933106 | 11,525 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 24,448 | 1,153,230 | SH | SOLE | 1,153,230 | 0 | 0 | ||
SUNSHINE HEART INC | COM | 86782U106 | 350 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
TETRAPHASE PHARMACEUTICALS I | COM | 88165N105 | 1,757 | 160,000 | SH | SOLE | 160,000 | 0 | 0 |